CD8
+ cells including human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes (CTLs) play important roles in controlling HIV-1 infection (Borrow et al., 1994; McMichael & Rowland-Jones, 2001) . It has been shown that CD8
+ cells of asymptomatic carriers produce an unknown CD8 + T-cell antiviral factor that can suppress HIV-1 replication at a transcriptional level without causing cell death (Mackewicz et al., 1995) .
We have demonstrated previously that anti-HIV-1 activities of CD8 + cells of asymptomatic carriers exhibit both major histocompatibility complex (MHC) I-restricted and -unrestricted suppression (Kannagi et al., 1990; Ohashi et al., 1999) , and that HIV-1-irrelevant CD8 + CTLs derived from uninfected donors also inhibit X4 and R5 HIV-1 replication (Liu et al., 2003) . Therefore, we hypothesized that MHC I-unrestricted suppression of HIV-1 replication might be a common property of CD8 + CTLs, regardless of HIV-1 infection in the host. However, in our system, such CD8 + cell-mediated suppression required direct contact between CD8 + cells and infected cells.
Whilst investigating CD8
+ cell-mediated HIV-1 suppression, we established four allo-specific CD8 + CTL lines, CTL-1 (Liu et al., 2003) , CTL-2, CTL-3 and CTL-4, from four uninfected healthy donors by stimulating peripheral blood mononuclear cells with mitomycin C (MMC)-treated Raji (Pulvertaft, 1964) cells in a long-term culture in the presence of recombinant human interleukin-2 (rhIL-2) as described previously (Liu et al., 2003) . These CTLs were not cytotoxic to autologous CD4 + cells, but significantly suppressed HIV-1 replication in HIV-1-infected autologous CD4
+ cells when directly co-cultured.
Among these CTL lines, we found that culture supernatants of CTL-3 suppressed HIV-1 replication in addition to cellmediated suppression. In the present study, we purified and identified the suppressive factor in the supernatant of CTL-3 by serial high-performance liquid chromatography (HPLC) and mass spectrometry. Fig. 1 shows representative data of HIV-1 suppression by the established allo-specific CD8 + CTL lines. CTLs from both the CTL-2 and CTL-3 lines markedly suppressed HIV-1 replication when directly co-cultured with HIV-1-infected autologous CD4
+ cells, whereas culture supernatants from CTL-3 but not CTL-2 suppressed HIV-1 replication (Fig. 1a) . Culture supernatants of CTL-3 suppressed replication of both X4 HIV-1 strain NL4-3 (Adachi et al., 1986) and R5 HIV-1 strain JR-CSF (Koyanagi et al., 1987) (Fig. 1b) . CTL-2 and CTL-3 culture supernatants did not alter the viability of CD4 + T cells during 4 days of culture.
In order to purify the suppressive factor(s), first we separated the CTL-3 culture supernatant on an anion-exchange UNO-Q1 column (Bio-Rad) with a linear gradient from 0 to 1?0 M NaCl in 10 mM potassium phosphate buffer (pH 7?0) using HPLC (Fig. 2a) . The HIV-1-suppressive Fig. 1 legend were concentrated with Amicon Ultra-4 (Millipore), applied to an anion-exchange column (UNO-Q1; Bio-Rad) and eluted with a linear gradient (0-1?0 M NaCl) in 10 mM potassium phosphate buffer at a flow rate of 1 ml min "1 using an HPLC system (BioCAD; Applied Biosystems). Protein peaks, conductivity and fraction numbers are indicated. (b) Each fraction was dialysed against PBS, cleared through a 0?22 mm filter, supplemented with 10 % FBS and added to an HIV-1 NL4-3-infected CD4
+ cell culture at a concentration of 50 %. The same volume of PBS with 10 % FBS was used as a control (open bar). After 4 days of incubation, the amount of HIV-1 p24 in the culture supernatants was measured by ELISA. The results indicate the mean±SD of duplicate wells. (c) Fraction #26 separated by anion-exchange HPLC was further subjected to gel filtration on a TSK gel 2000 column (Tosoh) using HPLC at a flow rate of 0?5 ml min "1 in PBS. Protein peaks, conductivity and fraction numbers are indicated. (d) Each gel-filtrated HPLC fraction was evaluated for HIV-1-suppressive activity as described in (b). (e) Fractions #26-13, -14 and -15, separated as described in (c) from two independently prepared samples, were subjected to 7?5 % SDS-PAGE at a constant current of 24 mA per gel for 5 h. The proteins were visualized by silver staining (ProteoSilver Plus Silver Stain kit; Sigma-Aldrich). Similarly purified fractions from culture supernatants containing MMC-treated Raji cells alone served as controls. The arrow at 45 kDa indicates the bands specific for the fractions with HIV-1-suppressive activity. (f) The protein band at 45 kDa was excised from the SDS-polyacrylamide gel, digested with lysyl endopeptidase and subjected to MALDI-TOF-MS using an Ultraflex TOF/TOF mass spectrometer (Bruker Daltonics) as described previously (Yamagata et al., 2002) . The MS spectrum of this protein as shown was analysed by MASCOT software (Matrix Science) with the NCBInr database and identified as arginine deiminase from M. arginini. activity of each fraction (1 ml) was evaluated following direct co-culture with CD4
+ cells infected with HIV-1 NL4-3. As shown in Fig. 2(b) , fractions #25 to #28 of anionexchange HPLC markedly suppressed the replication of HIV-1. The suppressive activity peaked at fraction #26 in more than three independent experiments. Fraction #26 was subsequently separated by gel filtration on a TSK gel 2000 column (Tosoh) using HPLC (Fig. 2c) . The resulting fractions, #14 and #15 (designated #26-14 and #26-15, respectively, hereafter) markedly suppressed HIV-1 replication (Fig. 2d) .
Next, HIV-1-suppressive fractions #26-14 and -15, serially purified by anion-exchange and gel-filtrated HPLC from CTL-3 supernatants, were resolved by 7?5 % SDS-PAGE. As a control, similarly purified fractions from culture supernatants of MMC-treated Raji cells were used. As shown in Fig. 2(e) , silver staining showed protein bands at 45 kDa that were observed only in #26-14 and -15, and not in the control fractions. The 45 kDa protein bands were cut from a separately prepared negatively stained gel (Wako) and subjected to matrix-assisted laser desorption/ionization timeof-flight mass spectrometry (MALDI-TOF-MS). Fig. 2(f) demonstrates the MS spectrum of peptides extracted from the 45 kDa band after digestion with lysyl endopeptidase, obtained using an Ultraflex TOF/TOF mass spectrometer (Kristensen et al., 2000; Yamagata et al., 2002) . Several peaks were analysed further by MS/MS (data not shown). Computer analysis of the MS and MS/MS spectra using MASCOT software (Matrix Science) with the NCBInr database identified the protein as arginine deiminase from Mycoplasma arginini. The results strongly indicated that the CTL-3 cells had been contaminated by M. arginini, although growth of the CTL-3 cells was not affected.
Finally, we examined whether the suppressive effects of CTL-3 supernatants on HIV-1 replication were attributed to arginine deiminase. Arginine deiminase is a mycoplasma enzyme that catalyses the imine hydrolysis of arginine to citrulline and ammonia. When L-arginine (10 mM) was added to an HIV-1-infected CD4
+ cell culture together with CTL-3 culture supernatant, the suppression of HIV-1 replication was almost completely restored (Fig. 3a) , clearly indicating that the suppressive effects were mediated mostly by arginine deiminase. L-Glysine (10 mM) as a control showed no effect. In addition, treatment of the CTL-3 culture with antibiotic MC210 against mycoplasma for approximately 2 weeks abolished the HIV-1-suppressive activity of the culture supernatants (Fig. 3a) .
In contrast, CTL-3 and MC210-treated CTL-3 cells continued to show significant levels of suppressive effects on HIV-1 replication when directly co-cultured with HIV-1-infected autologous CD4
+ cells in the presence of L-arginine (Fig. 3b) , indicating that cell-mediated suppression of HIV-1 replication was not attributed to arginine deiminase. The presence of cell-mediated but not supernatant-mediated suppressive effects on HIV-1 replication was also confirmed by using another mycoplasma-free CD8 + CTL line (CTL-4) (Fig. 3c) .
Our results clearly indicate that arginine deiminase from M. arginini suppresses HIV-1 replication in CD4 + cells in vitro. Although arginine is a non-essential amino acid for humans and mice, some cancers have an elevated requirement for arginine. Arginine deiminase inhibits the growth of argininerequiring tumours such as human melanomas and hepatocellular carcinoma in vitro and in vivo, suggesting its potential use as a chemotherapeutic reagent (Curley et al., 2003; Ensor et al., 2002) .
Mycoplasma contamination of HIV-1-infected culture causes various effects in vitro, such as enhancement of the cytopathic effects associated with HIV-1 replication (Lo et al., 1991) , inhibition of CD4 expression and gp120 binding (O'Toole & Lowdell, 1990 ) and apparent reduction of reverse transcriptase activity, probably due to nuclease activity (el-Farrash et al., 1994; Shang et al., 1995; Vasudevachari et al., 1990) . Mycoplasma penetrans isolated from HIV-1-infected individuals potentially activates T lymphocytes and HIV-1 replication, suggesting its contribution to disease progression . This variety of effects might partly be due to the variety of Mycoplasma species.
In the present study, we identified arginine deiminase as a suppressive factor of HIV-1 replication. Although we found it in a CD8 + CTL line possessing HIV-1-suppressive activity, only supernatant-mediated and not cell-contact-dependent suppression of HIV-1 was attributed to arginine deiminase. The precise mechanisms of arginine deiminase-mediated inhibition of the HIV-1 replication cycle remain to be clarified.
